These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18306229)

  • 1. Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma.
    Komori J; Marusawa H; Machimoto T; Endo Y; Kinoshita K; Kou T; Haga H; Ikai I; Uemoto S; Chiba T
    Hepatology; 2008 Mar; 47(3):888-96. PubMed ID: 18306229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers.
    Endo Y; Marusawa H; Kou T; Nakase H; Fujii S; Fujimori T; Kinoshita K; Honjo T; Chiba T
    Gastroenterology; 2008 Sep; 135(3):889-98, 898.e1-3. PubMed ID: 18691581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinomas associated with long-term inflammation express the activation-induced cytidine deaminase and germinal center-associated nuclear protein involved in immunoglobulin V-region diversification.
    Chan-On W; Kuwahara K; Kobayashi N; Ohta K; Shimasaki T; Sripa B; Leelayuwat C; Sakaguchi N
    Int J Oncol; 2009 Aug; 35(2):287-95. PubMed ID: 19578742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
    Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
    Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
    J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.
    Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
    Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis.
    Kou T; Marusawa H; Kinoshita K; Endo Y; Okazaki IM; Ueda Y; Kodama Y; Haga H; Ikai I; Chiba T
    Int J Cancer; 2007 Feb; 120(3):469-76. PubMed ID: 17066440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
    Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN
    Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation.
    Takai A; Marusawa H; Minaki Y; Watanabe T; Nakase H; Kinoshita K; Tsujimoto G; Chiba T
    Oncogene; 2012 Mar; 31(13):1733-42. PubMed ID: 21841819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree.
    Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y
    Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions.
    Endo K; Yoon BI; Pairojkul C; Demetris AJ; Sirica AE
    Hepatology; 2002 Aug; 36(2):439-50. PubMed ID: 12143054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling.
    Endo Y; Marusawa H; Kinoshita K; Morisawa T; Sakurai T; Okazaki IM; Watashi K; Shimotohno K; Honjo T; Chiba T
    Oncogene; 2007 Aug; 26(38):5587-95. PubMed ID: 17404578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of activation-induced cytidine deaminase in inflammation-associated cancer development.
    Marusawa H; Takai A; Chiba T
    Adv Immunol; 2011; 111():109-41. PubMed ID: 21970953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 Mutations in human cholangiocarcinoma: a review.
    Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD
    Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
    Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
    Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers.
    Itoi T; Shinohara Y; Takeda K; Takei K; Ohno H; Ohyashiki K; Yahata N; Ebihara Y; Saito T
    Gastrointest Endosc; 2000 Sep; 52(3):380-6. PubMed ID: 10968854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression.
    Morisawa T; Marusawa H; Ueda Y; Iwai A; Okazaki IM; Honjo T; Chiba T
    Int J Cancer; 2008 Dec; 123(12):2735-40. PubMed ID: 18781563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
    Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
    J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
    Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
    Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.